BGNE logo

BeiGene, Ltd. (BGNE)

Profile

Full Name

BeiGene, Ltd.

Ticker

NASDAQ: BGNE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Cayman Islands

IPO

February 3, 2016

Indexes

Not included

Website

https://www.beigene.com

Employees

10600

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.46B(+73.65% YoY)

Annual EPS

-$8.45(+56.38% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    -
    BGNE price value is unknown

    30-Day Relative Volume

    -
    BGNE 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    BGNE price change on Jan 1, 1 is unknown

    Price YTD change

    -
    BGNE price ytd change is unknown

    Price 1-year change

    -
    BGNE price 1-year change is unknown

    Price 3-year change

    -
    BGNE price 3-year change is unknown

    Price Range

    Price All-time high

    $426.56
    BGNE price is currently at an all-time high

    Price 3-year low

    $124.46
    BGNE price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    BGNE market capitalization value is unknown

    Market cap 3-year change

    -
    BGNE market capitalization 3-year change is unknown

    Market cap All-time high

    $37.51B
    BGNE market capitalization is currently at an all-time high

    Market cap sector rank

    -
    BGNE market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.37%
    BGNE shares outstanding is up +0.37% year-on-year

    Shares Outstanding 3-Year Change

    -5.35%
    BGNE shares outstanding is down -5.35% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -
    BGNE beta value is unknown

    200-day SMA

    -
    BGNE SMA 200 is unknown

    50-day SMA

    -
    BGNE SMA 50 is unknown

    RSI

    -
    BGNE 14-day relative strength index value is unknown

    Volume

    -
    BGNE 30-day relative volume value is unknown

    ATR

    -
    BGNE average true range value is unknown

    10-day Historical Volatility

    -
    BGNE 10-day historical volatility value is unknown

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.46B
    BGNE annual revenue is $2.46 billion

    Revenue Analysts estimate

    $3.71B
    BGNE annual revenue is currently -33.65% lower than the consensus analysts' forecast

    Revenue 1-year change

    +73.65%
    BGNE annual revenue is up +73.65% year-on-year

    Revenue Sector rank

    -
    BGNE annual revenue is unknown

    EPS

    EPS

    -$8.45
    BGNE annual earnings per share is -$8.45

    EPS Analysts estimate

    -$4.90
    BGNE annual earnings per share is currently +72.41% higher than the consensus analysts' forecast

    EPS 1-year change

    +56.38%
    BGNE annual earnings per share is up +56.38% year-on-year

    EPS Sector rank

    -
    BGNE annual earnings per share is unknown

    Profit

    Gross profit

    $2.08B
    BGNE annual gross profit is $2.08 billion

    Gross margin

    84.55%
    BGNE annual gross profit margin is 84.55%

    Operating profit

    -$1.21B
    BGNE annual operating income is -$1.21 billion

    Operating margin

    -49.12%
    BGNE annual operating profit margin is -49.12%

    Net income

    -$881.71M
    BGNE annual net profit is -$881.71 million

    Net margin

    -35.86%
    BGNE annual net profit margin is -35.86%

    Expenses

    Total expenses

    $3.67B
    BGNE annual total expenses is $3.67 billion

    Operating expenses

    $3.29B
    BGNE annual total operating expenses is $3.29 billion

    Cost of goods sold

    $379.92M
    BGNE annual cost of goods sold is $379.92 million

    Selling, general & administrative expenses

    $1.50B
    BGNE annual SGA is $1.50 billion

    Depreciation and amortization

    $87.67M
    BGNE annual depreciation & amortization is $87.67 million

    Interest expense

    -
    BGNE annual interest expense value is unknown

    Income tax

    $55.87M
    BGNE annual income tax is $55.87 million

    EBIT & EBITDA

    EBIT

    -$1.21B
    BGNE annual earnings before interest & taxes is -$1.21 billion

    EBITDA

    -$1.12B
    BGNE annual EBITDA is -$1.12 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.81B
    BGNE annual total assets is $5.81 billion

    Non current assets

    $1.60B
    BGNE annual long term assets is $1.60 billion

    Current assets

    $4.20B
    BGNE annual total current assets is $4.20 billion

    Cash and cash equivalents

    $3.17B
    BGNE annual cash & cash equivalents is $3.17 billion

    Accounts receivable

    $358.03M
    BGNE annual accounts receivable is $358.03 million

    Inventory

    $416.12M
    BGNE annual inventory is $416.12 million

    Liabilities

    Total liabilities

    $2.27B
    BGNE annual total liabilities is $2.27 billion

    Long term liabilities

    $457.83M
    BGNE annual total long term liabilities is $457.83 million

    Current liabilities

    $1.81B
    BGNE annual total current liabilities is $1.81 billion

    Accounts payable

    $315.11M
    BGNE annual accounts payable is $315.11 million

    Debt

    Total debt

    $930.18M
    BGNE annual total debt is $930.18 million

    Total debt 1-year change

    +55.89%
    BGNE annual total debt is up +55.89% year-on-year

    Long term debt

    $219.87M
    BGNE annual long term debt is $219.87 million

    Short term debt

    $710.32M
    BGNE annual short term debt is $710.32 million

    Equity & Capital

    Shareholders equity

    $3.54B
    BGNE annual stockholders equity is $3.54 billion

    Book value

    $3.54B
    BGNE annual book value is $3.54 billion

    Retained earnings

    -$7.96B
    BGNE annual retained earnings is -$7.96 billion

    Working capital

    $2.39B
    BGNE annual working capital is $2.39 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$1.16B
    BGNE annual cash flow from operations is -$1.16 billion

    Cash from operations 1-year change

    +22.66%
    BGNE annual cash flow from operations is up +22.66% year-on-year

    Cash from investing

    $60.00M
    BGNE annual cash flow from investing activities is $60.00 million

    Cash from investing 1-year change

    -94.43%
    BGNE annual cash flow from investing activities is down -94.43% year-on-year

    Cash from financing

    $416.48M
    BGNE annual cash flow from financing activities is $416.48 million

    Cash from financing 1-year change

    +2295.34%
    BGNE annual cash flow from financing activities is up +2295.34% year-on-year

    CAPEX

    CAPEX

    $596.26M
    BGNE annual capital expenditures is $596.26 million

    CAPEX 1-year change

    +27.11%
    BGNE annual capital expenditures is up +27.11% year-on-year

    Free Cash Flow

    Free cash flow

    -$1.75B
    BGNE annual free cash flow is -$1.75 billion

    Free cash flow 1-year change

    +10.79%
    BGNE annual free cash flow is up +10.79% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    84.55%
    BGNE annual gross profit margin is 84.55%

    Operating margin

    -49.12%
    BGNE annual operating profit margin is -49.12%

    Net margin

    -35.86%
    BGNE annual net profit margin is -35.86%

    ROA & ROE

    ROA

    -14.47%
    BGNE annual return on assets is -14.47%

    ROE

    -22.26%
    BGNE annual return on equity is -22.26%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BGNE price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BGNE price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    BGNE price to book ratio value is unknown

    PB ratio Sector rank

    -
    BGNE price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    BGNE price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BGNE price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    BGNE enterprise value value is unknown

    Enterprise value Sector rank

    -
    BGNE enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    BGNE EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    BGNE EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.32
    BGNE annual current ratio is 2.32

    Quick ratio

    2.09
    BGNE annual quick ratio is 2.09

    Leverage

    Debt to equity

    0.25
    BGNE annual debt to equity ratio is 0.25

    Interest coverage ratio

    -
    BGNE annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    BGNE piotroski f-score is 3

    Altman Z-Score

    -
    BGNE altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Nov 13, 24 TD Cowen
    Buy
    Oct 22, 24 JP Morgan
    Overweight
    Sep 18, 24 JMP Securities
    Market Outperform
    Aug 20, 24 JP Morgan
    Overweight
    Aug 8, 24 Citigroup
    Buy
    Jul 9, 24 B of A Securities
    Neutral
    May 9, 24 TD Cowen
    Buy
    Apr 24, 24 TD Cowen
    Buy
    Apr 8, 24 B of A Securities
    Neutral
    Mar 27, 24 Bernstein
    Market Perform

    Institutional Ownership

    Screeners with BGNE included

    No data
    • What is the ticker symbol for BeiGene, Ltd.?
    • Does BeiGene, Ltd. pay dividends?
    • What sector is BeiGene, Ltd. in?
    • What industry is BeiGene, Ltd. in?
    • What country is BeiGene, Ltd. based in?
    • When did BeiGene, Ltd. go public?
    • Is BeiGene, Ltd. in the S&P 500?
    • Is BeiGene, Ltd. in the NASDAQ 100?
    • Is BeiGene, Ltd. in the Dow Jones?
    • When was BeiGene, Ltd.'s last earnings report?
    • When does BeiGene, Ltd. report earnings?

    What is the ticker symbol for BeiGene, Ltd.?

    The ticker symbol for BeiGene, Ltd. is NASDAQ:BGNE

    Does BeiGene, Ltd. pay dividends?

    No, BeiGene, Ltd. does not pay dividends

    What sector is BeiGene, Ltd. in?

    BeiGene, Ltd. is in the Healthcare sector

    What industry is BeiGene, Ltd. in?

    BeiGene, Ltd. is in the Biotechnology industry

    What country is BeiGene, Ltd. based in?

    BeiGene, Ltd. is headquartered in Cayman Islands

    When did BeiGene, Ltd. go public?

    BeiGene, Ltd.'s initial public offering (IPO) was on February 3, 2016

    Is BeiGene, Ltd. in the S&P 500?

    No, BeiGene, Ltd. is not included in the S&P 500 index

    Is BeiGene, Ltd. in the NASDAQ 100?

    No, BeiGene, Ltd. is not included in the NASDAQ 100 index

    Is BeiGene, Ltd. in the Dow Jones?

    No, BeiGene, Ltd. is not included in the Dow Jones index

    When was BeiGene, Ltd.'s last earnings report?

    BeiGene, Ltd.'s most recent earnings report was on February 26, 2025

    When does BeiGene, Ltd. report earnings?

    The date for BeiGene, Ltd.'s next earnings report has not been announced yet
    On this page